Department of Hematology

Hematology Home >

Faculty

Donald Edward Tsai, M.D., Ph.D.

Associate Professor of Medicine at the Hospital of the University of Pennsylvania

Attending Physician

Department: Medicine

Contact information

Perelman Center for Advanced Medicine
2 West Pavilion
3400 Civic Center Boulevard
Philadelphia, PA 19104

Office: 215-614-0037
Fax: 215-662-4064

Email:
detsai@mail.med.upenn.edu

Education:
A.B. (Biochemistry)
Harvard College, Cambridge, MA, 1986.
Ph.D. (Microbiology & Immunology)
Duke University, Durham, NC, 1993.
M.D. (Medicine)
Duke University School of Medicine, Durham, NC, 1994.

Post-Graduate Training
Intern in Internal Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, 1994-1995.
Resident in Internal Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, 1995-1996.
Post doctoral Fellowship, Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, 1996-2000.

Certifications
Internal Medicine, American Board of Internal Medicine, 1997.
Medical Oncology, American Board of Internal Medicine, 2001.

Permanent link

> School of Medicine > Faculty > Details

Description of Research Expertise

Posttransplant Lymphoproliferative Disorder

Description of Clinical Expertise

Hematologic Malignancy and Stem Cell Transplantation

Selected Publications

Porter DL, Levine BL, Bunin N, Stadtmauer EA, Luger SL, Goldstein S, Loren A, Phillips J, Nasta S, Perl A, Schuster S, Tsai D, Sohal A, Velosa E, Emerson S, June CH: A phase I trial of donor lymphocyte infusions expanded and activated ex vivo via CD3/CD28 costimulation. Blood 107: 1325-1331, 2006.

Elstrom RL, Andreadis C, Aqui N, Ahya A, Bloom R, Brozena S, Olthoff K, Schuster S, Nasta S, Stadtmauer E, Tsai DE: Treatment of PTLD with rituximab or chemotherapy. American Journal of Transplantation 6: 569-576, 2006.

Milone M, Tsai DE, Hodinka R, Silverman LB, Malbran A, Wasik MA, Nichols KE: Treatment of primary Epstein-Barr virus infection in patients with X-linked lymphoproliferative disease using B-cell directed therapy. Blood 105: 994-996, 2005.

Misleh J, Loren A, Ahya V, Kotloff R, Douglas L, Aqui N, Tsai D: Presentation, treatment, and outcome of 24 patients with post-transplant lymphoproliferative disorder (PTLD) after lung transplantation. International Society for Heart and Lung Transplantation, 25th Annual Meeting 2005 Notes: Oral Presentation.

Tsai DE, Aqui NA, Tomaszewski JE, Olthoff KM, Ahya VN, Kotloff RM, Bloom RD, Brozena SC, Hodinka RL, Stadtmauer EA, Schuster SJ, Nasta SD, Porter DL, Luger SM, Klumpp TR: Serum protein electrophoresis abnormalities in adult solid organ transplant patients with post-transplant lymphoproliferative disorder. Clinical Transplantation 19: 644-652, 2005.

Vogl D, Schuster S, Glattstein E, Carver J, Tsai DE: Gemcitabine induced symptomatic pericardial effusion after unblocked cardiac irradiation. Leukemia & Lymphoma 46: 1313-1320, 2005.

Hewitt M, Porter D, Hummel K, McAlee A, Phillips J, Stadtmauer E, Schuster S, Luger S, Nasta S, Tsai D, Loren A, Perl A, Emerson S, Goldstein S: Myeloablative vs non-myeloablative conditioning with allogeneic stem cell transplantation for high risk non-Hodgkin's lymphoma: similar outcomes despite differences in disease risk. 2005 Tandem BMT Meetings 2005.

Tsai DE, Aqui NA, Vogl RD, Bloom RD, Schuster SJ, Nasta SD, Wasik MA: Successful treatment of T-cell post-transplant lymphoproliferative disorder with the retinoid analog bexarotene American Journal of Transplantation 5: 2070-2073, 2005.

Chong EA, Svoboda J, Downs LH, Zhuang H, Alavi A, Tsai DE, Schuster SJ. : Response of pulmonary MALT lymphoma to treatment with rituximab. Leukemia & Lymphoma 46: 1383-1386, 2005.

Svoboda J, Andreadis C, Downs, Downs LH, Miller WT, Tsai DE Schuster SJ: Regression of advanced non-splenic marginal zone lymphoma after treatment of hepatitis C virus infection. Leukemia & Lymphoma 46: 1365-1368, 2005.